Levothyroxine Bioequivalence Studies Need Thyroid-Free Baseline – Abbott
Executive Summary
FDA should require generic companies to conduct levothyroxine bioequivalence studies in athyreotic patients as a condition of ANDA approval, Abbott suggests in an Aug. 25 citizen petition